Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer

被引:138
作者
Albo, D
Wayne, JD
Hunt, KK
Rahlfs, TF
Singletary, SE
Ames, FC
Feig, BW
Ross, MI
Kuerer, HM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Anesthesiol, Houston, TX 77030 USA
关键词
anaphylaxis; isosulfan blue; surgery; sentinel lymph node; breast cancer;
D O I
10.1016/S0002-9610(01)00734-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Sentinel lymph node biopsy (SLNB) is an alternative to axillary dissection for many breast cancer patients. Cases of anaphylactic reaction to the isosulfan blue dye used during SLNB have recently been reported. No study on the incidence of serious anaphylactic reactions during SLNB for breast cancer has been reported. Methods: We reviewed 639 consecutive SLNBs for breast cancer performed at our institution. Sentinel lymph node biopsy was performed using both isosulfan blue dye and technetium-99m sulfur colloid. Cases of anaphylaxis were reviewed in detail. Results: Overall, 1.1% of patients had severe anaphylactic reactions to isosulfan blue requiring vigorous resuscitation. No deaths or permanent disability occurred. In patients with anaphylaxis, hospital stay was prolonged by a mean of 1.6 days. In 1 patient, the anaphylactic reaction required termination of the operation. Conclusions: Prompt recognition and aggressive treatment of anaphylactic reactions to isosulfan blue are critical to prevent an adverse outcome. Lymphatic mapping with blue dye should be performed in a setting where personnel are trained to recognize and treat anaphylaxis. (C) 2001 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 40 条
  • [1] Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
    Albertini, JJ
    Lyman, GH
    Cox, C
    Yeatman, T
    Balducci, L
    Ku, NN
    Shivers, S
    Berman, C
    Wells, K
    Rapaport, D
    Shons, A
    Horton, J
    Greenberg, H
    Nicosia, S
    Clark, R
    Cantor, A
    Reintgen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1818 - 1822
  • [2] Arreaza E E, 1989, Tex Med, V85, P36
  • [3] Sentinel node biopsy in breast cancer
    Barnwell, JM
    Arredondo, MA
    Kollmorgen, D
    Gibbs, JF
    Lamonica, D
    Carson, W
    Zhang, P
    Winston, J
    Edge, SB
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (02) : 126 - 130
  • [4] ANAPHYLAXIS
    BOCHNER, BS
    LICHTENSTEIN, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (25) : 1785 - 1790
  • [5] Complementarity of blue dye and isotope in sentinel node localization for breast cancer: Univariate and multivariate analysis of 966 procedures
    Cody, HS
    Fey, J
    Akhurst, T
    Fazzari, M
    Mazumdar, M
    Yeung, H
    Yeh, SDJ
    Borgen, PI
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (01) : 13 - 19
  • [6] Coleman RL, 1999, J SURG ONCOL, V70, P126, DOI 10.1002/(SICI)1096-9098(199902)70:2<126::AID-JSO12>3.3.CO
  • [7] 2-G
  • [8] AXILLARY NODE STATUS IN NONPALPABLE BREAST-CANCER
    DOWLATSHAHI, K
    SNIDER, HC
    KIM, R
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (05) : 424 - 428
  • [9] FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765
  • [10] FISHER M, 1994, EUR J ANAESTH, V11, P263